News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,508 Results
Type
Article (27050)
Company Profile (76)
Press Release (455382)
Multimedia
Podcasts (81)
Webinars (8)
Section
Business (152945)
Career Advice (1760)
Deals (24535)
Drug Delivery (79)
Drug Development (49072)
Employer Resources (114)
FDA (10737)
Job Trends (11288)
News (242381)
Policy (22318)
Tag
Academia (1915)
Academic (1)
Accelerated approval (5)
Adcomms (16)
Allergies (57)
Alliances (42050)
ALS (79)
Alzheimer's disease (1142)
Antibody-drug conjugate (ADC) (81)
Approvals (10743)
Artificial intelligence (235)
Autoimmune disease (15)
Automation (15)
Bankruptcy (214)
Best Places to Work (9345)
BIOSECURE Act (14)
Biosimilars (57)
Biotechnology (50)
Bladder cancer (60)
Brain cancer (13)
Breast cancer (224)
Cancer (1748)
Cardiovascular disease (144)
Career advice (1488)
Career pathing (25)
CAR-T (96)
Cell therapy (337)
Cervical cancer (17)
Clinical research (39961)
Collaboration (756)
Compensation (353)
Complete response letters (10)
COVID-19 (1766)
CRISPR (33)
C-suite (165)
Cystic fibrosis (63)
Data (1802)
Decentralized trials (2)
Denatured (27)
Depression (28)
Diabetes (204)
Diagnostics (5365)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (33)
Drug discovery (96)
Drug pricing (98)
Drug shortages (19)
Duchenne muscular dystrophy (79)
Earnings (64609)
Editorial (38)
Employer branding (13)
Employer resources (99)
Events (69712)
Executive appointments (542)
FDA (11765)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (535)
Gene editing (78)
Generative AI (20)
Gene therapy (257)
GLP-1 (496)
Government (3411)
Grass and pollen (5)
Guidances (151)
Healthcare (14650)
Huntington's disease (16)
IgA nephropathy (19)
Immunology and inflammation (85)
Indications (25)
Infectious disease (1866)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (35)
Intellectual property (70)
Interviews (322)
IPO (11136)
IRA (40)
Job creations (2330)
Job search strategy (1246)
Kidney cancer (5)
Labor market (30)
Layoffs (277)
Leadership (17)
Legal (5370)
Liver cancer (47)
Lung cancer (246)
Lymphoma (119)
Machine learning (5)
Management (37)
Manufacturing (273)
MASH (59)
Medical device (9120)
Medtech (9124)
Mergers & acquisitions (13889)
Metabolic disorders (509)
Multiple sclerosis (61)
NASH (11)
Neurodegenerative disease (70)
Neuropsychiatric disorders (17)
Neuroscience (1556)
NextGen: Class of 2025 (5071)
Non-profit (3789)
Now hiring (15)
Obesity (254)
Opinion (174)
Ovarian cancer (56)
Pain (64)
Pancreatic cancer (57)
Parkinson's disease (113)
Partnered (16)
Patents (166)
Patient recruitment (78)
Peanut (27)
People (39619)
Pharmaceutical (20)
Pharmacy benefit managers (13)
Phase I (12252)
Phase II (17422)
Phase III (13595)
Pipeline (1206)
Policy (137)
Postmarket research (1798)
Preclinical (5160)
Press Release (68)
Prostate cancer (106)
Psychedelics (22)
Radiopharmaceuticals (177)
Rare diseases (280)
Real estate (4572)
Recruiting (47)
Regulatory (15089)
Reports (29)
Research institute (1765)
Resumes & cover letters (266)
Rett syndrome (3)
RNA editing (3)
RSV (25)
Schizophrenia (55)
Series A (88)
Series B (49)
Service/supplier (16)
Sickle cell disease (47)
Special edition (14)
Spinal muscular atrophy (76)
Sponsored (25)
Startups (2070)
State (1)
Stomach cancer (11)
Supply chain (56)
Tariffs (29)
The Weekly (53)
Vaccines (474)
Venture capitalists (21)
Weight loss (156)
Women's health (26)
Worklife (13)
Date
Today (161)
Last 7 days (770)
Last 30 days (2381)
Last 365 days (23957)
2025 (9038)
2024 (25383)
2023 (28479)
2022 (37196)
2021 (39806)
2020 (39475)
2019 (35804)
2018 (26746)
2017 (23035)
2016 (22422)
2015 (25644)
2014 (20649)
2013 (18110)
2012 (18489)
2011 (18467)
2010 (17045)
Location
Africa (631)
Alabama (45)
Alaska (6)
Arizona (134)
Arkansas (10)
Asia (26744)
Australia (4278)
California (4383)
Canada (1658)
China (365)
Colorado (228)
Connecticut (231)
Delaware (127)
Europe (64531)
Florida (735)
Georgia (159)
Hawaii (1)
Idaho (30)
Illinois (437)
India (23)
Indiana (249)
Iowa (5)
Japan (141)
Kansas (76)
Kentucky (18)
Louisiana (9)
Maine (37)
Maryland (743)
Massachusetts (3373)
Michigan (169)
Minnesota (232)
Mississippi (2)
Missouri (54)
Montana (18)
Nebraska (17)
Nevada (52)
New Hampshire (40)
New Jersey (1416)
New Mexico (22)
New York (1292)
North Carolina (824)
North Dakota (7)
Northern California (1945)
Ohio (160)
Oklahoma (11)
Oregon (24)
Pennsylvania (1019)
Puerto Rico (7)
Rhode Island (24)
South America (901)
South Carolina (19)
Southern California (1690)
Tennessee (91)
Texas (676)
United States (17395)
Utah (142)
Virginia (105)
Washington D.C. (55)
Washington State (392)
West Virginia (3)
Wisconsin (40)
482,508 Results for "kcas bioanalytical and biomarker services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
KCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers
KCAS Bioanalytical and Biomarker Services closed the purchase of Active Biomarkers located in Lyon, France.
September 12, 2022
·
5 min read
Press Releases
U.S. Cell and Gene Therapy Bioanalytical Testing Services Market Size to Surpass USD 349.29 Mn by 2034
February 26, 2025
·
1 min read
Press Releases
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
January 9, 2025
·
2 min read
Press Releases
Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America
February 4, 2025
·
3 min read
BioMidwest
KCAS Bioanalytical and Biomarker Services Welcomes Senior Director of Biopharmaceutical Services
KCAS Bioanalytical and Biomarker Services, a laboratory services focused contract research organization is pleased to announce the addition of.
April 30, 2021
·
2 min read
BioMidwest
KCAS Bioanalytical and Biomarker Services Announces Expansion of Biopharma Leadership, Including John Pirro
KCAS Bioanalytical and Biomarker Services, a leading bioanalytical services laboratory, is pleased to announce the expansion of leadership for the Biopharmaceutical Services team.
June 2, 2021
·
3 min read
BioMidwest
KCAS Bioanalytical and Biomarker Services Welcomes Dr. Greg Veltri as Scientific Director of Biopharmaceutical Services
KCAS Bioanalytical and Biomarker Services, a laboratory services focused contract research organization is pleased to announce the expansion of their Biopharmaceutical Services team.
July 12, 2021
·
2 min read
Business
KCAS Bioanalytical and Biomarker Services Welcomes Dr. Jeff Hester
KCAS Bioanalytical and Biomarker Services, a laboratory services focused contract research organization (CRO), is pleased to announce the expansion of their Biopharmaceutical Services team. Dr. Jeff Hester, Ph.D., joins KCAS to lead the buildup and growth of the organization’s Cell and Gene Therapy Services.
May 11, 2021
·
2 min read
Business
Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services
Vitruvian Partners, one of the world’s leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area.
April 15, 2021
·
4 min read
Deals
KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners portfolio Company, announces acquisition of FlowMetric, LLC
KCAS: Continuing to deliver against both growth objectives and more integrated customer service offerings, KCAS has acquired FlowMetric, LLC, a leading provider of flow cytometry and cellular assay R&D services to biotech, pharmaceutical and cell/gene therapy industries.
February 3, 2022
·
4 min read
1 of 48,251
Next
